INCY vs JPM Stock Comparison
INCY currently leads JPM in this stock comparison, with AIQ scores of 64 vs 52. The clearest difference is quality, while JPM has the stronger momentum profile.
What is the main difference between INCY and JPM?
INCY leads the current stock comparison as Incyte Corporation, with the clearest separation coming from quality and the broader AIQ evidence mix.
AlgovestIQ AIQ Comparison
Incyte Corporation vs JPMorgan Chase & Co.
INCY leads
INCY leads by 12 AIQ points, primarily on Quality and Value, but the lead has narrowed from 21 points over 30 sessions. Wall Street currently favors JPM on target upside.
Stable: 4 of 6 evidence groups support INCY, its lead is narrowing, and its signal state is cleanly positive.
Incyte Corporation
JPMorgan Chase & Co.
The Algovestiq AIQ Score currently favors INCY over JPM, 64 versus 52 as of Oct 21, 2026. INCY's advantage is driven primarily by stronger quality and value, while JPM holds the stronger momentum profile. INCY also shows the weaker technical structure relative to its 50-day moving average, though analyst target upside currently favors JPM. 4 of 6 covered evidence groups favor INCY today, and the comparison is rated Stable on stability: the leader's advantage has been narrowing. INCY lead: Weakening — the AIQ differential moved from 21 to 12 points over 30 sessions.
Compare Incyte Corporation and JPMorgan Chase & Co. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.
Performance over time
Total return with distributions reinvested, from daily closes.
Total return comparison
Growth of $10,000, distributions reinvested
Split-adjusted closes; each distribution is reinvested at the close on its ex-dividend date. Taxes and trading costs are not modeled.
Compare INCY and JPM against another ticker
Open a multi-ticker workspace without changing this focused pair page.
AIQ Factor Divergence
Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.
- Quality90 vs 46INCY +44
- Momentum40 vs 58JPM +18
- Value52 vs 44INCY +8
- Risk Resilience74 vs 68INCY +6
4 of 6 evidence groups favor INCY. INCY’s edge is concentrated in quality and value; JPM keeps a meaningful momentum edge.
What changed since the last close
Latest scored session 2026-10-20, compared against the prior scored session 2026-10-19.
Largest factor move: Momentum +10
New signals
- MACD Bullish Crossover — bullish, momentum, short horizon
Largest factor move: Momentum +8
No signal started or stopped since the prior session; its 2 active signals are unchanged.
INCY's lead was unchanged in the latest session.
Deeper signal detail for each name lives on its own signals page — INCY and JPM both carry a full feed there.
The central trade-off
INCY (Incyte Corporation): the stronger current systematic profile, led by quality and value.
JPM (JPMorgan Chase & Co.): the counter-case, on momentum, analyst expectations.
The AIQ Score and Wall Street therefore point in different directions on this pair.
Which one fits your objective
The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.
Balanced
INCYINCY on the overall AIQ Score, which weights Quality and Value most heavily.
Growth
INCYINCY on combined revenue and EPS growth.
Value
INCYINCY on the peer-relative Value factor, by 8 points.
Momentum
JPMJPM on the Momentum factor, by 18 points.
Lower downside
INCYINCY on Risk Resilience, by 6 points.
Analyst upside
JPMJPM on implied upside to the consensus price target.
AIQ vs Wall Street
The model and the Street disagree here: AIQ favors INCY, analyst targets favor JPM. That disagreement is the most useful thing on this page.
| Measure | INCY | JPM | Note |
|---|---|---|---|
| Implied upside to target | +9.9% | +11.3% | JPM has more room |
| Target dispersion | +53.7% | +32.2% | Lower is tighter analyst agreement |
| Consensus | Hold | Buy | Context, not a primary driver |
| Analysts covering | 15 | 11 | Higher coverage generally improves confidence |
The two are measuring different things. The AIQ Score reads current fundamentals, valuation, trend and risk; analyst targets price forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something already priced in — it is worth resolving before acting on either.
Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.
AIQ Agreement Matrix
4 of 6 covered evidence groups favor INCY. A wide gap backed by one group is a weaker case than a narrow gap backed by five.
| Evidence group | Favors | Reading |
|---|---|---|
| AIQ Score | INCY | 64 vs 52 |
| Fundamentals | INCY | revenue growth 31.5% vs -7.6%; EPS growth 92.1% vs -27.6%; TTM ROE 29.7% vs 17.9%; gross margin 92.6% vs 63.2%; operating margin 31.6% vs 28.2% |
| Valuation | INCY | Value 52 vs 44 |
| Technicals | Even | Price vs 50-day -6.7% vs -3.4%; vs 200-day 8.3% vs 4% |
| Risk Resilience | INCY | Risk Resilience 74 vs 68 |
| Analyst expectations | JPM | Target upside 9.9% vs 11.3% |
✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of INCY and JPM and are excluded from the count.
AIQ Decision Stability
The conclusion rests on a wide gap and broad agreement. It is unlikely to turn on a single session.
- The AIQ gap is wide at 12 points. (supports the conclusion holding)
- The leader's advantage has been narrowing. (argues the conclusion is provisional)
- The leader's signal state is cleanly positive. (supports the conclusion holding)
Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on INCY.
How the comparison changed
120 daily snapshots · Jun 21 – Oct 20INCY lead: Weakening — the AIQ differential moved from 21 to 12 points over 30 sessions.
- Today
- INCY +12
- 64 vs 52
- 7 sessions ago
- INCY +14
- 61 vs 47
- 30 sessions ago
- INCY +21
- 64 vs 43
- 90 sessions ago
- INCY +12
- 65 vs 53
The lead has not changed hands in this window.
AIQ Signal Divergence
Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.
INCY and JPM carry the same 2 signals, so the signals do not separate them: Golden Cross Active, MACD Bullish Crossover.
Price vs model alignment
Whether the latest session's price move confirms what the model did over the same session, or contradicts it.
Price is down while the AIQ Score moved up 3 points over the same session — price and model disagree (price -2.72%, AIQ +3 points).
Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price -0.02%, AIQ +3 points).
What would flip this result
A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.
- 1JPM closes the Quality gap — currently 44 points behind, the largest single contributor to INCY's edge.
- 2JPM generates a confirmed bullish trend signal it does not currently carry, such as EMA Ribbon Expansion Bullish or Uptrend Structure Active.
- 3INCY's Golden Cross Active breaks down — it is the strongest rule currently supporting the verdict.
- 4The narrowing continues — the lead has already given back 9 points over 30 sessions, and a further 12-point move would eliminate INCY's advantage entirely.
The full evidence
Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.
Fundamentals
INCY leads on balance| Metric | INCY | JPM |
|---|---|---|
| Revenue growth (YoY) | 31.5% | -7.6% |
| EPS growth (YoY) | 92.1% | -27.6% |
| Gross margin | 92.6% | 63.2% |
| Operating margin | 31.6% | 28.2% |
| Return on equity (TTM) | 29.7% | 17.9% |
| Debt to equity | 0.01 | 3.32 |
Performance
INCY leads 5 of 6 windows| Metric | INCY | JPM |
|---|---|---|
| 1 week (5 sessions) | 7.4% | 1.2% |
| 1 month (20 sessions) | -8.1% | -1.4% |
| 3 months (63 sessions) | 0.7% | -3.7% |
| 6 months (126 sessions) | 21.2% | 7.1% |
| Year to date | 18.1% | 4% |
| 1 year (252 sessions) | 33.6% | 12.3% |
Technicals
Split| Metric | INCY | JPM |
|---|---|---|
| RSI (14) | 39.5 | 57.4 |
| ADX (14) | 25.2 | 20.5 |
| Price vs 50-day | -6.7% | -3.4% |
| Price vs 200-day | 8.3% | 4% |
| Volatility (1M, annualized) | 25.4% | 14.8% |
Risk
INCY is the more resilient| Metric | INCY | JPM |
|---|---|---|
| Beta | 0.4 | 0.75 |
| Sharpe ratio | 0.91 | 0.47 |
| Sortino ratio | 1.55 | 0.66 |
| Max drawdown | -18.3% | -15.5% |
| Current drawdown | -10.3% | -8.2% |
| Annualized volatility | 33.4% | 22.2% |
| Value at risk (95%) | -2.7% | -2.4% |
Straight answers
Each answer is regenerated from the current snapshot, not written once and left to age.
Which is better, INCY or JPM?
On the Algovestiq AIQ Score, INCY is the stronger of the two as of Oct 21, 2026, scoring 64 against JPM's 52. The edge comes from quality and value. JPM is not without a case — it holds the better momentum profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.
Is INCY or JPM the better buy right now?
INCY carries the stronger systematic profile as of Oct 21, 2026, and the comparison is rated Stable — 4 of 6 covered evidence groups agree. A Stable rating means the gap is wide and the evidence is broad, so the conclusion is unlikely to turn on a single session.
Why does the AIQ Score favor INCY over JPM?
The composite weights Quality, Value, Momentum and Risk Resilience. INCY leads Quality by 44 points; JPM leads Momentum by 18 points; INCY leads Value by 8 points. Where the two split, the factor with the larger weight carries the result.
Which has more analyst upside, INCY or JPM?
Analyst price targets imply +9.9% upside for INCY and +11.3% for JPM, so the Street currently favors JPM. That points the opposite way to the AIQ Score, which favors INCY. The two are measuring different things: the model reads current fundamentals, valuation, trend and risk; the Street is pricing forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something the analysts have already priced — it is the single most useful row on this page to investigate. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.
Which is better value, INCY or JPM?
INCY is the better-valued of the two on the peer-relative Value factor. INCY on the peer-relative Value factor, by 8 points. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.
Which has stronger growth, INCY or JPM?
INCY on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.
Which has stronger momentum, INCY or JPM?
JPM on the Momentum factor, by 18 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.
Which is riskier, INCY or JPM?
INCY is the more resilient of the two, so the other name carries the higher downside risk. INCY on Risk Resilience, by 6 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.
Is INCY more profitable than JPM?
INCY leads on the comparable margin measures — gross margin 92.6% vs 63.2%; operating margin 31.6% vs 28.2%; ttm roe 29.7% vs 17.9%.
Is INCY's lead over JPM getting stronger or weaker?
INCY lead: Weakening — the AIQ differential moved from 21 to 12 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-06-21 and 2026-10-20. The lead has not changed hands in that window.
What would change the INCY vs JPM verdict?
The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: JPM closes the Quality gap — currently 44 points behind, the largest single contributor to INCY's edge; JPM generates a confirmed bullish trend signal it does not currently carry, such as EMA Ribbon Expansion Bullish or Uptrend Structure Active; INCY's Golden Cross Active breaks down — it is the strongest rule currently supporting the verdict; the narrowing continues — the lead has already given back 9 points over 30 sessions, and a further 12-point move would eliminate INCY's advantage entirely.
What do the current signals say about INCY and JPM?
INCY: 2 bullish / 0 bearish. JPM: 2 bullish / 0 bearish. The most decision-relevant rule on INCY is Golden Cross Active (bullish, long horizon). On JPM it is Golden Cross Active (bullish, long horizon).
Compare INCY and JPM with others
Continue your research
This page answers which of the two. These answer the questions on either side of it.
How this comparison is scored
The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.
The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.
How to use side-by-side comparison →This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.